Status:
COMPLETED
Rapid Evaluation for Stroke Outcomes Using Lytics in Vascular Event (RESOLVE) Registry and Implementation Quality Improvement Study
Lead Sponsor:
Saint Luke's Health System
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Despite abundant evident supporting the use of acute reperfusion therapy in the setting of acute ischemic stroke (AIS), adoption of this practice in routine clinical care is poor. We hypothesize that ...
Detailed Description
Specific Aim 1: Implement ePRISM and the RESOLVE Decision Aid (DA) at 2 sites (Saint Luke's Hospital in Kansas City and Saint Luke's North) for Emergency Department (ED) access and decision support. ...
Eligibility Criteria
Inclusion
- Acute ischemic stroke
- 18 years of age or older
Exclusion
- Active internal bleeding
- History of cerebrovascular accident
- Evidence of intracranial hemorrhage on pretreatment evaluation
- Suspicion of subarachnoid hemorrhage on pretreatment evaluation
- Recent (within 3 months) intracranial or intraspinal surgery, serious head trauma, or previous stroke
- History of intracranial hemorrhage
- Uncontrolled hypertension at time of treatment
- Seizure at the onset of stroke
- Intracranial neoplasm, arteriovenous malformation, or aneurysm
- Known bleeding diathesis
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT01864928
Start Date
July 1 2013
End Date
December 31 2016
Last Update
October 19 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.